Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
Holding BTAI?
Track your performance easily

Bioxcel Therapeutics (BTAI) Financial Statements

1,334 Followers

Bioxcel Therapeutics Financial Overview

Bioxcel Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.554; its P/E ratio is -0.19; Bioxcel Therapeutics is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 1.10M$ 582.00K$ 376.00K$ 341.00K$ 457.00K
Gross Profit$ 1.04M$ 502.00K$ -337.00K$ -171.00K$ 431.00K
EBIT$ -4.70M$ -23.18M$ -18.82M$ -47.23M$ -50.61M
EBITDA$ -4.45M$ -22.99M$ -18.74M$ -47.16M$ -50.10M
Net Income Common Stockholders$ -8.30M$ -26.79M$ -22.26M$ -50.49M$ -50.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 56.27M$ 74.14M$ 65.22M$ 89.96M$ 127.55M
Total Assets$ 65.44M$ 82.32M$ 73.70M$ 100.45M$ 140.10M
Total Debt$ 103.26M$ 101.98M$ 101.04M$ 99.62M$ 97.46M
Net Debt$ 46.99M$ 27.84M$ 35.82M$ 9.66M$ -30.08M
Total Liabilities$ 139.27M$ 154.69M$ 130.21M$ 141.06M$ 134.23M
Stockholders Equity$ -74.30M$ -72.36M$ -56.51M$ -40.61M$ 5.86M
Cash Flow-
Free Cash Flow$ -23.17M$ -17.71M$ -26.86M$ -37.58M$ -38.23M
Operating Cash Flow$ -23.17M$ -17.71M$ -26.86M$ -37.58M$ -38.21M
Investing Cash Flow----$ -20.00K
Financing Cash Flow$ 5.30M$ 26.63M$ 2.12M-$ 250.00K
Currency in USD

Bioxcel Therapeutics Earnings and Revenue History

Bioxcel Therapeutics Debt to Assets

Bioxcel Therapeutics Cash Flow

Bioxcel Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis